Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens

Arab Journal of Gastroenterology

Volumn 14, Issue 2, 2013, Pages 55-58

  Vafaeimanesh, Jamshid ^a   Rajabzadeh, Rabeah ^b   Ahmadi, Anahita ^b   Moshtaghi, Mounes ^b   Banikarim, Seyedamir ^b   Hajiebrahimi, Shahin ^b   Seyyedmajidi, Mohammadreza ^b  

^a QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glycaemia control; Helicobacter pylori; Treatment protocols; Type 2 diabetes mellitus

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; GLUCOSE; HEMOGLOBIN A1C; METRONIDAZOLE; OMEPRAZOLE;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT DURATION; UREA BREATH TEST;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED;

EID: 84879787252     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2013.03.002     Document Type: Article

References (25)

1. Kaufman F.R. Diabetes mellitus. Pediatr Rev 1997, 18(11):383-392. Quiz 393.
2. Candelli M., Rigante D., Marietti G., et al. Helicobacter pylori, gastrointestinal symptoms and metabolic control in young type 1 diabetes mellitus patients. Pediatrics 2003, 111(4):800-803.
3. Begue R.E., Mirza A., Compton T., et al. Helicobacter pylori infection and insulin requirement among children with type 1 diabetes mellitus. Pediatrics 1999, 103(6):e83.
4. Sargýn M., Uygur-Bayramiçli O., Sargýn H., et al. Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. World J Gastroenterol 2003, 9(5):1126-1128.
5. Xia H.H.N., Talley N.J., Kam E.P.Y., et al. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001, 96(4):1039-1046.
6. Uygur-Bayramiçli O., Kiliç D., Yavuzer D., et al. Helicobacter pylori colonization and immunological disease. Eur J Gastroenterol Hepatol 2001, 13(3):301-302.
7. Demir M., Gokturk H.S., Ozturk N.A., et al. Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study. Am J Med Sci 2009, 338(6):459-464.
8. Gené E., Calvet X., Azagra R., et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Alimen Pharmacol Therap 2003, 17(9):1137-1143.
9. Katelaris P.H., Forbes G.M., Talley N.J., et al. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE study. Gastroenterology 2002, 123(6):1763-1769.
10. Laine L., Hunt R., EI-Zimaity H., et al. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole and tetracycline given with omeprazole versus omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. Am J Gastroenterol 2003, 98(3):562-567.
11. Laine L. Is it time for quadruple therapy to be first line?. Helicobacter pylori: Basic mechanisms to clinical cure 2002, 347-351. Kluwer Academic Publishers, Dordrecht. L. Laine (Ed.).
12. Calvet X., Ducons J., Guardiola J., et al. One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial. Alimen Pharmacol Therap 2002, 16(7):1261-1267.
13. Gomollón F., Valdepérez J., Garuz R., et al. Analisis coste-efectividad de dos estrategias de erradicacion de Helicobacter pylori: Resultados de un estudio prospectivo y aleatorizado en atencion primaria [Cost/effectiveness analysis of two strategies for Helicobacter pylori eradication: Results of a prospective and randomized study in primary care setting]. Med Clin 2000, 115(1):1-6.
14. Tseng C.H. Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study. BMC Gastroenterol 2012, 12. Art. No. 46.
15. Polyzos S.A., Kountouras J., Zavos C., et al. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011, 16(2):79-88.
16. Seyyedmajidi M., Falaknazi K., Mirsattari D., et al. Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: a randomised clinical trial. Arab J Gastroenterol 2011, 12(3):150-153.
17. Wurzer H., Rodrigo L., Stamler D., et al. Short-course therapy with Amoxycillin-Clarithormycin Triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. Alimen Pharmacol Therap 1997, 11(5):943-952.
18. Viara D., Ali A., Gatta L., et al. Treatment of Helicobacter pylori. Curr Opin Gastroenterol 1998, 14(Suppl. 1):71-78.
19. Malfertheiner P., Megraud F., O'Morain C., et al. Current concepts in the management of Helicobacter pylori infection: the maastricht III consensus report. Gut 2007, 56(6):772-781.
20. Uygun A., Kadayifci A., Safali M., et al. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. J Dig Dis 2007, 8(4):211-215.
21. Demir M., Göktürk S., Öztürk N.A., et al. Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients. Digestion 2010, 82(1):47-53.
22. Georgopoulos S.D., Ladas S.D., Karatapanis S., et al. Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies. Alimen Pharmacol Therap 2002, 16(3):569-575.
23. Ataseven H., Demir M., Gen R. Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus. South Med J 2010, 103(10):988-992.
24. Van Zwet A.A., Mégraud F. Diagnosis. Curr Opin Gastroenterol 1998, 14(Suppl. 1). S27-33.
25. Moghimi J., Toussy J., Babaei M., et al. Effect of Helicobacter pylori eradication on short-term control of glycemia in patients with type 2 diabetes mellitus. Saudi Med J 2007, 28(3):475-476.